Botulinum Toxin Application in Facial Esthetics and Recent Treatment Indications (2013-2018)

Vivekanand Kattimani, Rahul Vinay Chandra Tiwari, Khalid Gufran, Bharti Wasan, P H Shilpa, Anas Abdul Khader, Vivekanand Kattimani, Rahul Vinay Chandra Tiwari, Khalid Gufran, Bharti Wasan, P H Shilpa, Anas Abdul Khader

Abstract

Background: Ever-changing perception of beauty from childhood to old age is changing with the revolution in cosmeceuticals science. Esthetics is an individual's perception since time immemorial. Standards of beauty have changed through centuries with increased awareness about esthetics. The face remains main source of information for identification and discrimination. It constitutes a structural ground for many nonverbal messages including the emotional state of a person, so the proverb "Face is an index of mind" holds good. The wrinkles and laxity are considered to be one of the factors for aging. Hence, escalating demand for cosmetic treatment to reduce facial wrinkles and laxity has stimulated us to search for published literature for nonsurgical techniques for enhancement of facial beauty. The review analyzed the published data to provide narrative basic review in a concise way to the beginners, clinicians, and students.

Materials and methods: We have adopted search criteria using keywords: Botox, Botulinum toxin, incobotulinumtoxinA, esthetics, face, uses of Botox, with various Boolean operators and or in title, and abstract using PubMed search engine. The database search limited to PubMed only from January 2013 to June 2018.

Results: Various search results have been appended as annexures at the end of the article for further reference for the readers. Finally, 17 references were selected to write narrative review to meet our objectives.

Conclusion: The advancing front in the use of toxins is an emerging science for the beautification of a face. Botox exploded in to market because of efficacy, tolerability, and minimally invasive nature. The present review gives brief about the history of Botulinum toxin, types, mechanism of action, clinical indications, preparations, storage, and technique for various uses with a brief note on patient selection, contraindications, and complications.

Keywords: Aging; botulinum toxin; cosmetics; esthetics; face; noninvasive procedure; wrinkles.

Conflict of interest statement

There are no conflicts of interest.

References

    1. Konda D, Thappa DM. Age reversing modalities: An overview. Indian J Dermatol Venereol Leprol. 2013;79:3–8.
    1. Singh G. Can we prevent skin aging? Indian J Dermatol Venereol Leprol. 2009;75:447–51.
    1. Ilankovan V. Anatomy of ageing face. Br J Oral Maxillofac Surg. 2014;52:195–202.
    1. Dastoor SF, Misch CE, Wang HL. Botulinum toxin (Botox) to enhance facial macroesthetics: A literature review. J Oral Implantol. 2007;33:167–71.
    1. Harmon CB, Hadley ML. A cosmetic approach to cutaneous defects. Atlas Oral Maxillofac Surg Clin North Am. 2004;12:141–62.
    1. Stupak HD, Maas CS. New procedures in facial plastic surgery using botulinum toxin A. Facial Plast Surg Clin North Am. 2003;11:515–20.
    1. Jandhyala R. Impact of botulinum toxin a on the quality of life of subjects following treatment of facial lines. J Clin Aesthet Dermatol. 2013;6:41–5.
    1. Moriarty KC. Botulinum Toxin in Facial Rejuvenation. 1st ed. Spain: Mosby; 2003.
    1. Jaspers GW, Pijpe J, Jansma J. The use of botulinum toxin type A in cosmetic facial procedures. Int J Oral Maxillofac Surg. 2011;40:127–33.
    1. Cartee TV, Monheit GD. An overview of botulinum toxins: Past, present, and future. Clin Plast Surg. 2011;38:409–26, vi.
    1. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43:249–50.
    1. Lam SM. The basic science of botulinum toxin. Facial Plast Surg Clin North Am. 2003;11:431–8.
    1. Carruthers A, Carruthers J. Botulinum toxin type A. J Am Acad Dermatol. 2005;53:284–90.
    1. Niamtu J., 3rd Aesthetic uses of botulinum toxin A. J Oral Maxillofac Surg. 1999;57:1228–33.
    1. Matsudo PK. Botulinum toxin for correction of fronto-glabella wrinkles: Preliminary evaluation. Aesthetic Plast Surg. 1996;20:439–41.
    1. Blitzer A, Binder WJ. Current practices in the use of botulinum toxin A in the management of facial lines and wrinkles. Facial Plast Surg Clin North Am. 2001;9:395–404.
    1. Sarrabayrouse MA. Indications and limitations for the use of botulinum toxin for the treatment of facial wrinkles. Aesthetic Plast Surg. 2002;26:233–8.
    1. Chen AH, Frankel AS. Altering brow contour with botulinum toxin. Facial Plast Surg Clin North Am. 2003;11:457–64.
    1. Bassichis BA, Thomas JR. The use of botox to treat glabellar rhytids. Facial Plast Surg Clin North Am. 2003;11:453–6.
    1. Kim DW, Cundiff J, Toriumi DM. Botulinum toxin A for the treatment of lateral periorbital rhytids. Facial Plast Surg Clin North Am. 2003;11:445–51.
    1. Zimbler Facsa MS, Nassif PS. Adjunctive applications for botulinum toxin in facial aesthetic surgery. Fac Plast Surg Clin N Am. 2003;11:477–82.
    1. Ziade M, Domergue S, Batifol D, Jreige R, Sebbane M, Goudot P, et al. Use of botulinum toxin type A to improve treatment of facial wounds: A prospective randomised study. J Plast Reconstr Aesthet Surg. 2013;66:209–14.
    1. Snider CC, Amalfi AN, Hutchinson LE, Sommer NZ. New insights into the anatomy of the midface musculature and its implications on the nasolabial fold. Aesthetic Plast Surg. 2017;41:1083–90.
    1. Wu DC, Fabi SG, Goldman MP. Neurotoxins: Current concepts in cosmetic use on the face and neck – Lower face. Plast Reconstr Surg. 2015;136:76S–9S.
    1. Qaqish C. Botulinum toxin use in the upper face. Atlas Oral Maxillofac Surg Clin North Am. 2016;24:95–103.
    1. Baumeister JC, Papa G, Foroni F. Deeper than skin deep – The effect of botulinum toxin-A on emotion processing. Toxicon. 2016;118:86–90.
    1. Nestor M, Ablon G, Pickett A. Key parameters for the use of abobotulinumtoxinA in aesthetics: Onset and duration. Aesthet Surg J. 2017;37:S20–31.
    1. Miller J, Clarkson E. Botulinum toxin type A: Review and its role in the dental office. Dent Clin North Am. 2016;60:509–21.
    1. Kordestani R, Small KH, Rohrich RJ. Advancements and refinement in facial neuromodulators. Plast Reconstr Surg. 2016;138:803–6.
    1. Bertossi D, Mortellaro C, Nocini P. New clinical analysis and device for botox injections. J Craniofac Surg. 2016;27:1554–7.
    1. Chen H, Pan W, Zhang J, Cheng H, Tan Q. The application of W-plasty combined botox-A injection in treating sunk scar on the face. Medicine (Baltimore) 2018;97:e11427.
    1. Jones DH, Kerscher M, Geister T, Hast MA, Weissenberger P. Efficacy of incobotulinumtoxinA for the treatment of glabellar frown lines in male subjects: Post hoc analyses from randomized, double-blind pivotal studies. Dermatol Surg. 2017;43(Suppl 2):S235–41.
    1. Solish N, Rivers JK, Humphrey S, Muhn C, Somogyi C, Lei X, et al. Efficacy and safety of onabotulinumtoxinA treatment of forehead lines: A multicenter, randomized, dose-ranging controlled trial. Dermatol Surg. 2016;42:410–9.
    1. Hsu AK, Frankel AS. Modification of chin projection and aesthetics with onabotulinumtoxinA injection. JAMA Facial Plast Surg. 2017;19:522–7.
    1. de Almeida AR, Romiti A, Carruthers JD. The facial platysma and its underappreciated role in lower face dynamics and contour. Dermatol Surg. 2017;43:1042–9.
    1. Zhou R, Pan B, Wang C, Wang D. Mandibular rim trilogy with botulinum toxin injection: Reduction, projection, and lift. Facial Plast Surg. 2017;33:102–8.
    1. Gart MS, Gutowski KA. Overview of botulinum toxins for aesthetic uses. Clin Plast Surg. 2016;43:459–71.
    1. Rivers JK, Bertucci V, McGillivray W, Muhn C, Rosen N, Solish N, et al. Subject satisfaction with onabotulinumtoxinA treatment of glabellar and lateral canthal lines using a new patient-reported outcome measure. Dermatol Surg. 2015;41:950–9.
    1. Erickson BP, Lee WW, Cohen J, Grunebaum LD. The role of neurotoxins in the periorbital and midfacial areas. Facial Plast Surg Clin North Am. 2015;23:243–55.
    1. Prager W, Nogueira Teixeira D, Leventhal PS. IncobotulinumtoxinA for aesthetic indications: A systematic review of prospective comparative trials. Dermatol Surg. 2017;43:959–66.
    1. Steinsapir KD, Rootman D, Wulc A, Hwang C. Cosmetic microdroplet botulinum toxin A forehead lift: A new treatment paradigm. Ophthalmic Plast Reconstr Surg. 2015;31:263–8.
    1. Sharova AA. Comparison of different consensuses of BTXA in different countries. J Cosmet Dermatol. 2016;15:540–8.
    1. Charles PD. Botulinum neurotoxin serotype A: A clinical update on non-cosmetic uses. Am J Health Syst Pharm. 2004;61:S11–23.
    1. Awan KH. The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions – An evidence based review. Saudi Pharm J. 2017;25:18–24.
    1. Zhang EZ, Tan S, Loh I. Botolinum toxin in rhinitis: Literature review and posterior nasal injection in allergic rhinitis. Laryngoscope. 2017;127:2447–54.
    1. Halpern L, Willis P. Orofacial pain: Pharmacologic paradigms for therapeutic intervention. Dent Clin North Am. 2016;60:381–405.
    1. Vikelis M, Argyriou AA, Dermitzakis EV, Spingos KC, Makris N, Kararizou E, et al. Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment. J Headache Pain. 2018;19:87.
    1. Bolshinsky V, Gurland B, Hull TL, Zutshi M. Levator ani syndrome: Transperineal botox injections. Tech Coloproctol. 2018;22:465–6.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe